Stocks
Wave Life Sciences, Inc.WVE
NASDAQHealthcareBiotechnology$3.21
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing nucleic acid therapeutics, including RNA interference and antisense oligonucleotides, for rare genetic diseases and neurological disorders. Its lead programs target Huntington's disease, alpha-1 antitrypsin deficiency, and Duchenne muscular dystrophy, with recent clinical data driving investor interest.
52W Range: $3.04-$21.73
Congressional Interest in Wave Life Sciences, Inc. (WVE)
No congressional trades have been disclosed for Wave Life Sciences, Inc. (WVE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading WVE?
No congressional trades found for this stock.